Combating antimicrobial resistance in malaria, HIV and tuberculosis

Area of Science:

• Infectious Diseases
• Pharmacology
• Molecular Biology

Background:

• Antimicrobial resistance (AMR) is a critical global health threat, jeopardizing treatments for malaria, HIV, and tuberculosis.
• The emergence and spread of drug resistance necessitate novel therapeutic strategies.

Purpose of the Study:

• To review the current status and molecular mechanisms of drug resistance in malaria, HIV, and tuberculosis.
• To discuss strategies for developing next-generation therapies that mitigate and combat AMR.
• To explore inter-disease knowledge transfer for innovative anti-infective drug discovery.

Main Methods:

• Comprehensive literature review of existing research on drug resistance in malaria, HIV, and tuberculosis.
• Analysis of molecular mechanisms underlying resistance in these pathogens.
• Evaluation of current and emerging strategies for next-generation drug development.

Main Results:

• Drug resistance mechanisms vary significantly across malaria, HIV, and tuberculosis.
• Current strategies for combating resistance are pathogen-specific.
• Cross-disciplinary approaches show promise for novel anti-infective development.

Conclusions:

• Effective management of AMR requires tailored strategies for each disease.
• Interdisciplinary collaboration can accelerate the discovery of new anti-infective treatments.
• Proactive implementation of resistance mitigation strategies is crucial for sustainable infectious disease control.